Cyclacel Pharmaceuticals Inc (CYCC)

Apr 25, 2025

Cyclacel Pharmaceuticals expands share authorization By Investing.com - Investing.com India

Apr 25, 2025

Apr 25, 2025

Major Shareholders Set to Sell Stocks; Company (TICKER) to Reap No Proceeds | CYCC Stock News - GuruFocus

Apr 25, 2025

Apr 25, 2025

Cyclacel Pharmaceuticals Inc Inc. (CYCC) Price Performance: A Technical Analysis Perspective - investchronicle.com

Apr 25, 2025

Apr 25, 2025

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) Could Actually Go To 1 In 12 Months - Marketing Sentinel

Apr 25, 2025

Apr 25, 2025

Cyclacel Pharmaceuticals (CYCC) Announces Quarterly Dividend - GuruFocus

Apr 25, 2025

Apr 24, 2025

Was Cyclacel Pharmaceuticals Inc (CYCC)’s session last reading good? - uspostnews.com

Apr 24, 2025

Apr 24, 2025

StockNews.com Initiates Coverage on Cyclacel Pharmaceuticals (NASDAQ:CYCC) - Defense World

Apr 24, 2025

Apr 23, 2025

Trading (CYCCP) With Integrated Risk Controls - news.stocktradersdaily.com

Apr 23, 2025

Apr 21, 2025

Cyclacel Pharmaceuticals announces preferred stock dividend By Investing.com - Investing.com Canada

Apr 21, 2025

Apr 16, 2025

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Coverage Initiated at StockNews.com - Defense World

Apr 16, 2025

Apr 07, 2025

When (CYCCP) Moves Investors should Listen - news.stocktradersdaily.com

Apr 07, 2025

Apr 05, 2025

Cyclacel Pharmaceuticals Inc (CYCC) Q2 2024 Earnings Call Transc - GuruFocus

Apr 05, 2025

Apr 05, 2025

Fitters Diversified To Dispose Subsidiary To Nasdaq Listed Pharma Firm - businesstoday.com.my

Apr 05, 2025

Apr 04, 2025

Fitters plans to sell full stake in unit to US biotech firm - The Malaysian Reserve

Apr 04, 2025

Apr 03, 2025

Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update - The Manila Times

Apr 03, 2025

Apr 03, 2025

Cyclacel Pharmaceuticals Shifts Focus to Cancer Drug Development - TipRanks

Apr 03, 2025

Apr 02, 2025

Cyclacel Pharmaceuticals, Inc. SEC 10-K Report - TradingView

Apr 02, 2025

Apr 02, 2025

Cyclacel Pharmaceuticals Appoints New Directors Amid Strategic Shift - TipRanks

Apr 02, 2025

Apr 02, 2025

Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results And Provides Business Update - MarketScreener

Apr 02, 2025

Mar 31, 2025

Cyclacel Pharmaceuticals Delays 10-K Filing - TipRanks

Mar 31, 2025

Mar 31, 2025

CYCC stock touches 52-week low at $0.29 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

CYCC stock touches 52-week low at $0.29 amid sharp annual decline - Investing.com

Mar 31, 2025

Mar 31, 2025

Financial Contrast: Cellectar Biosciences (NASDAQ:CLRB) versus Cyclacel Pharmaceuticals (NASDAQ:CYCC) - Defense World

Mar 31, 2025

Mar 26, 2025

Cyclacel Pharmaceuticals to offer convertible preferred stock in private placement - MSN

Mar 26, 2025

Mar 24, 2025

Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering Of Convertible Preferred Stock - Marketscreener.com

Mar 24, 2025

Mar 24, 2025

Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering of Convertible Preferred Stock - The Manila Times

Mar 24, 2025

Mar 23, 2025

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by Analysts at StockNews.com - Defense World

Mar 23, 2025

Mar 17, 2025

Cyclacel Pharmaceuticals’ Change of Control Transaction and Appointment of New Executive Leadership - Global Legal Chronicle

Mar 17, 2025

Mar 17, 2025

(CYCCP) Trading Advice - news.stocktradersdaily.com

Mar 17, 2025

Mar 16, 2025

Cyclacel Pharmaceuticals (CYCC) Projected to Post Earnings on Tuesday - The AM Reporter

Mar 16, 2025

Mar 15, 2025

CYCLACEL PHARMACEUTICALS Earnings Preview: Recent $CYCC Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 15, 2025

Mar 15, 2025

StockNews.com Begins Coverage on Cyclacel Pharmaceuticals (NASDAQ:CYCC) - Defense World

Mar 15, 2025

Mar 14, 2025

Cyclacel Pharmaceuticals acquires cancer drug assets By Investing.com - Investing.com Australia

Mar 14, 2025

Mar 14, 2025

Cyclacel Pharmaceuticals acquires cancer drug assets - Investing.com

Mar 14, 2025

Mar 12, 2025

Cyclacel stock plunges to 52-week low at $0.3 amid market challenges - Investing.com Australia

Mar 12, 2025

Mar 12, 2025

Cyclacel stock plunges to 52-week low at $0.3 amid market challenges By Investing.com - Investing.com South Africa

Mar 12, 2025

Mar 11, 2025

Cyclacel Pharmaceuticals (CYCC) to Release Earnings on Tuesday - Defense World

Mar 11, 2025

Mar 09, 2025

Cyclacel stock plunges to 52-week low of $0.31 amid market challenges - MSN

Mar 09, 2025

Mar 07, 2025

Cyclacel Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025

Feb 28, 2025

Cyclacel Pharmaceuticals interim CEO David Lazar sells $5.5 million in stock - Investing.com India

Feb 28, 2025

Feb 27, 2025

Cyclacel Pharmaceuticals Announces New Leadership and Restructuring - TipRanks

Feb 27, 2025